MyFinsight
Home
Blog
About
Contact
Download
Download image
Net change in cash
and cash...
-$18,484K
Stock-based compensation
expense
$876K
Amortization of right of
use-assets
$174K
Prepaid expenses and
other current assets
-$141K
Other non-current
liabilities
$11K
Proceeds from exercise of
stock options
$35K
Maturities of marketable
securities
$10,497K
Net cash used in
operating activities
-$14,800K
Net cash provided by
(used in) financing...
-$3,244K
Net cash used in
investing activities
-$440K
Canceled cashflow
$1,202K
Canceled cashflow
$35K
Canceled cashflow
$10,497K
Net loss
-$10,619K
Deposits and other
non-current assets
$3,452K
Accounts payable
-$871K
Payment of issuance
costs in connection...
$3,279K
Purchases of marketable
securities
$10,937K
Operating lease
liabilities
-$559K
Accrued expenses and
other current...
-$494K
Accretion of discounts on
marketable securities, net
$7K
Back
Back
Cash Flow
ImageneBio, Inc. (IMA)
ImageneBio, Inc. (IMA)
source: myfinsight.com